Stock HOWL WEREWOLF THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Werewolf Therapeutics, Inc.

Equities

HOWL

US95075A1079

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
4.89 USD -2.20% Intraday chart for Werewolf Therapeutics, Inc. +0.82% +26.68%
May. 03 Werewolf Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 23 Werewolf Therapeutics, Inc. Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease at AAI Annual Meeting CI

Evolution of the average Target Price on Werewolf Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

3c4f879c4c7f7fb2fbcb2c6d0f5c1.3K-X6DCouzG0e_0hif8UN5XWr8iD55OYIqdRSF52BDE.mM3BoGjx40GAHplWzpRFYt2JyqDg1arbRfgCOQtBYUmE36GyauHyWtI_rA~56f0efb405a59ffdfb0ef95f3385dedd

Analyst Recommendations on Werewolf Therapeutics, Inc.

JMP Securities Starts Werewolf Therapeutics With Market Outperform Rating, $12 Price Target MT
Wedbush Starts Werewolf Therapeutics at Outperform With $9 Price Target MT
EF Hutton Starts Werewolf Therapeutics at Buy With $8.30 Price Target MT
History shows stocks can weather rate hike cycle RE
SVB Leerink Adjusts Werewolf Therapeutics' Price Target to $28 from $29, Keeps Outperform Rating MT
WEREWOLF THERAPEUTICS : BofA Securities Initiates Coverage on Werewolf Therapeutics With Buy Rating, $26 Price Target MT
WEREWOLF THERAPEUTICS : Evercore ISI Group Initiates Werewolf Therapeutics at Outperform With $23 Price Target MT
WEREWOLF THERAPEUTICS : SVB Leerink Initiates Coverage on Werewolf Therapeutics With Outperform Rating, $29 Price Target MT
WEREWOLF THERAPEUTICS : HC Wainwright Starts Werewolf Therapeutics at Buy With $32 Price Target MT
WEREWOLF THERAPEUTICS : Jefferies Starts Werewolf Therapeutics at Buy With $22 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.89 USD
Average target price
12 USD
Spread / Average Target
+145.40%
High Price Target
15 USD
Spread / Highest target
+206.75%
Low Price Target
9 USD
Spread / Lowest Target
+84.05%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Werewolf Therapeutics, Inc.

JMP Securities
Wedbush
EF Hutton
SVB Leerink
BofA Securities
Jefferies & Co.
HC Wainwright
Evercore ISI

Ratings for Werewolf Therapeutics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. HOWL Stock
  4. Consensus Werewolf Therapeutics, Inc.